KinesioTaping: impact on non-motor symptoms in cervical dystonia patients treated with botulinum toxin injection

Neurol Neurochir Pol. 2024;58(1):127-133. doi: 10.5603/PJNNS.a2023.0042. Epub 2023 Jun 28.

Abstract

Aim of the study: To assess whether combined therapy with botulinum toxin injections (BoNT) and KinesioTaping could be helpful in managing non-motor symptoms (NMS) of cervical dystonia (CD).

Material and methods: Seventeen patients with CD were enrolled in this single-centre, prospective, evaluator-blinded, randomised, crossover trial. We compared three forms of treatment: BoNT treatment alone, or combined with KinesioTaping, or combined with ShamTaping. NMS were assessed using the 14-item self-reported questionnaire proposed by Klingelhoefer, the Hospital Anxiety and Depression Scale (HADS) and the Pittsburgh Sleep Quality Index (PSQI).

Results: There were no significant differences between the groups concerning mean results of HADS and PSQI scales, or mean total number of NMS after the procedures. The mean change from baseline HADS and PSQI scores, and total number of NMS after the procedure, also did not differ significantly between groups. ShamTaping combined with BoNT significantly increased the prevalence of pain.

Conclusions and clinical implications: Our study did not confirm the effectiveness of combined therapy of BoNT and KinesioTaping in the management of NMS in patients with CD. Due to a potential negative effect of improper taping on pain in CD, patients with CD should only experience KinesioTaping as an adjunctive therapy, and if it is performed by a trained, experienced physiotherapist.

Keywords: KinesioTaping; botulinum toxin injection; cervical dystonia; non-motor symptoms.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Athletic Tape*
  • Botulinum Toxins* / therapeutic use
  • Humans
  • Pain / chemically induced
  • Pain / drug therapy
  • Prospective Studies
  • Torticollis* / drug therapy
  • Treatment Outcome

Substances

  • Botulinum Toxins